Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
86.03
+3.02 (3.64%)
At close: Nov 6, 2026, 4:00 PM EST
88.00
+1.97 (2.29%)
After-hours: Nov 6, 2026, 7:30 PM EST

Dianthus Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.722.046.242.836.421.48
Revenue Growth
-11.70%-67.35%120.63%-55.96%334.76%-
Gross Profit
2.722.046.242.836.421.48
Operating Income
-236.03-177.93-101.86-48.17-29.71-13.09
Net Income
-202.12-162.34-84.97-43.56-28.48-13.11
Earnings Per Share
-3.91-4.20-2.55-8.45-32.57-3.27
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,244514.43356.97173.7275.497.64
Total Debt
1.211.391.490.590.79-
Net Cash (Debt)
1,243513.04355.48173.1374.77.64
Net Cash Growth
124.22%44.32%105.32%131.76%878.03%-
Net Cash Per Share
24.0613.2910.6733.6085.451.91

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-175.15-129.06-78.18-36.86-29.07-9.9
Capital Expenditures
-0.7-0.21-0.11-0.11-0.14-0.03
Free Cash Flow
-175.85-129.27-78.29-36.97-29.21-9.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-8683.89%-8739.34%-1633.75%-1704.67%-462.91%-886.59%
Pretax Margin
-7436.50%-7973.33%-1362.77%-1541.22%-443.76%-888.14%
Profit Margin
-7436.50%-7973.33%-1362.78%-1541.22%-443.76%-888.14%
FCF Margin
-6469.87%-6349.36%-1255.57%-1308.24%-455.18%-673.24%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1782.41867.84103.4854.53--